AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 76 filers reported holding AKCEA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,750,000 | +26.8% | 317,000 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $4,534,000 | +16.6% | 330,979 | +21.7% | 0.00% | 0.0% |
| Q1 2020 | $3,889,000 | -54.3% | 272,020 | -45.9% | 0.00% | 0.0% |
| Q4 2019 | $8,516,000 | +115.1% | 502,782 | +95.4% | 0.00% | 0.0% |
| Q3 2019 | $3,960,000 | -31.4% | 257,311 | +4.5% | 0.00% | 0.0% |
| Q2 2019 | $5,776,000 | -15.3% | 246,320 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $6,821,000 | -49.7% | 240,797 | -46.5% | 0.00% | 0.0% |
| Q4 2018 | $13,564,000 | +85.2% | 450,068 | +115.3% | 0.00% | 0.0% |
| Q3 2018 | $7,322,000 | +52.0% | 209,084 | +2.9% | 0.00% | +100.0% |
| Q2 2018 | $4,816,000 | -9.2% | 203,131 | -1.9% | 0.00% | -50.0% |
| Q1 2018 | $5,304,000 | +49.4% | 207,139 | +1.3% | 0.00% | +100.0% |
| Q4 2017 | $3,550,000 | -36.3% | 204,540 | +1.6% | 0.00% | -50.0% |
| Q3 2017 | $5,572,000 | – | 201,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |